Brief: Ardelyx Says FDA Approves Xphozah, A First-In-Class Phosphate Absorption Inhibitor
Oct 17 (Reuters) - Ardelyx Inc ARDX.O :
* FDA APPROVES XPHOZAH® (TENAPANOR), A FIRST-IN-CLASS
PHOSPHATE
ABSORPTION INHIBITOR
* COMMERCIAL LAUNCH UNDERWAY WITH PRODUCT EXPECTED TO BE
AVAILABLE
IN NOVEMBER
Source text for Eikon: ID:nGNX4pJWxv
Further company coverage: ARDX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Ardelyx
See all newsArdelyx, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ardelyx says Q2 product revenue at record high but IBSRELA revenue below expectations
Brief: Ardelyx Q2 Product Sales USD 118.129 Million
Ardelyx Q1 product revenue rises 38% on IBSRELA growth
Brief: Ardelyx Q1 Product Sales USD 93.373 Million